Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Jesse E. Medellin

Hematology Oncology | Oncology
Texas Oncology
Texas Oncology PA
1200 Brooklyn Ave, Suite 115, 
San Antonio, TX 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Texas Oncology
Texas Oncology PA
1200 Brooklyn Ave, Suite 115, 
San Antonio, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jesse Medellin is a Hematologist Oncology specialist and an Oncologist in San Antonio, Texas. Dr. Medellin is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Saddle Pulmonary Embolism, Large-Cell Immunoblastic Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL). Dr. Medellin is currently accepting new patients.

His clinical research consists of participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in TX
Hospital Affiliations
Methodist Hospital
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community First Health Plans
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

TEXAS ONCOLOGY PA
1200 Brooklyn Ave, Suite 115, San Antonio, TX 78212
Call: 210-224-6531

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)
A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)
Enrollment Status: Active_not_recruiting
Publish Date: August 14, 2025
Intervention Type: Drug
Study Drug: Tepotinib
Study Phase: Phase 2
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Canakinumab
Study Phase: Phase 3
View 1 Less Clinical Trial
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rebecca E. Barrington
Oncology | Hematology Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rebecca E. Barrington
Oncology | Hematology Oncology

Texas Oncology PA

694 Hill Country Dr, 
Kerrville, TX 
 (57.4 miles away)
830-792-3434
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Rebecca Barrington is an Oncologist and a Hematologist Oncology provider in Kerrville, Texas. Dr. Barrington is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Paget Disease of the Breast, Large-Cell Immunoblastic Lymphoma, Colorectal Cancer, and Childhood Iron Deficiency Anemia. Dr. Barrington is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Alyssa G. Rieber
Hematology Oncology | Oncology | Hematology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Alyssa G. Rieber
Hematology Oncology | Oncology | Hematology

Texas Oncology PA

506 W Windcrest St, Suite 300, 
Fredericksburg, TX 
 (61.6 miles away)
830-990-0255
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alyssa Rieber is a Hematologist Oncology specialist and an Oncologist in Fredericksburg, Texas. Dr. Rieber is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Breast Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Rieber is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Vijay K. Gunuganti
Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Vijay K. Gunuganti
Oncology

Texas Oncology PA

18707 Hardy Oak Blvd, Suite 320, 
San Antonio, TX 
 (12.2 miles away)
210-545-6972
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vijay Gunuganti is an Oncologist in San Antonio, Texas. Dr. Gunuganti is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Myelodysplastic Syndrome (MDS), Multiple Myeloma, Lung Cancer, and Renal Cell Carcinoma (RCC). Dr. Gunuganti is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Medellin's expertise for a condition
ConditionClose
    • Distinguished
    • Familial Colorectal Cancer
      Dr. Medellin is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Advanced
    • Acute Mountain Sickness
      Dr. Medellin is
      Advanced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Childhood Iron Deficiency Anemia
      Dr. Medellin is
      Advanced
      . Learn about Childhood Iron Deficiency Anemia.
      See more Childhood Iron Deficiency Anemia experts
    • Diffuse Large B-Cell Lymphoma (DLBCL)
      Dr. Medellin is
      Advanced
      . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
      See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
    • Iron Deficiency Anemia
      Dr. Medellin is
      Advanced
      . Learn about Iron Deficiency Anemia.
      See more Iron Deficiency Anemia experts
    • Large-Cell Immunoblastic Lymphoma
      Dr. Medellin is
      Advanced
      . Learn about Large-Cell Immunoblastic Lymphoma.
      See more Large-Cell Immunoblastic Lymphoma experts
    • Saddle Pulmonary Embolism
      Dr. Medellin is
      Advanced
      . Learn about Saddle Pulmonary Embolism.
      See more Saddle Pulmonary Embolism experts
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Medellin is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Medellin is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anemia
      Dr. Medellin is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Angiosarcoma
      Dr. Medellin is
      Experienced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Appendix Cancer
      Dr. Medellin is
      Experienced
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    • B-Cell Lymphoma
      Dr. Medellin is
      Experienced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    View All 54 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved